Parenteral Formulations

Nutrition Support for the Critically Ill Patient: A Guide to Practice

Volumn , Issue , 2016, Pages 279-302

  Christensen, Michael L ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69049112529     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420039191-24     Document Type: Chapter

References (108)

1. Dudrick, S.J. et al., Long-term TPN with growth, development, and positive nitrogen balance, Surgery, 64, 134, 1968.
2. Wilmore, D.W. and Dudrick, S.J., Growth and development of an infant receiving all nutrients exclusively by vein, JAMA, 203, 140, 1968.
3. Heyland, D.K. et al., TPN in the critically ill patient: meta analysis, JAMA, 280, 2013, 1998.
4. Heyland, D.K. et al., Total parenteral nutrition in the surgical patient: a meta-analysis, Can. J. Surg., 44, 102, 2001.
5. Torosian, M.H., Perioperative nutrition support for patients undergoing gastrointestinal surgery: critical analysis and recommendations, World J. Surg., 23, 565, 1999.
6. McGeer, A.J., Detsky, A.S., and O’Rourke, K., Parenteral nutrition in cancer patients undergoing chemotherapy: a meta analysis, Nutrition, 6, 233, 1990.
7. Koretz, R.L., Lipman, T.O., and Klein, S., AGA technical review on parenteral nutrition, Gastroenterology, 212, 770, 2001.
8. Guideline for the use of parenteral and enteral nutrition in adult and pediatric patients, JPEN, 26, 1SA, 2002.
9. Holliday, M.A. and Segar, W.E., The maintenance need for water in parenteral fluid therapy, Pediatrics, 19, 823, 1957.
10. Food and Nutrition Board, Institute of Medicine, Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids, National Academy Press, Washington, DC, 2002.
11. Flancbaum, L. et al., Comparison of indirect calorimetry, the Fick method, and prediction equations in estimating the energy requirements of critically ill patients, Am. J. Clin. Nutr., 69, 461, 1999.
12. Reeves, M.M. and Capra, S., Predicting energy requirements in the clinical settings: are methods evidence based? Nutr. Rev., 61, 143, 2003.
13. MacDonald, A. and Hildebrandt, L., Comparison of formulaic equations to determine energy expenditure in the critically ill patient, Nutrition, 19, 233, 2003.
14. Phelps, S.P. and Cochran, E.B., Effect of the continuous administration of fat emulsion on the infiltration of intravenous lines in infants receiving peripheral parenteral nutrition solutions, JPEN, 13, 628, 1989.
15. Randolph, A.G. et al., Benefit of heparin in peripheral venous and arterial catheters, BMJ, 316, 969, 1998.
16. Shah, P. and Shah, V., Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters, Cochrane Database Syst. Rev., 3, CD002772, 2001.
17. Barrington, K.J., Umbilical artery catheters in the newborn: effects of heparin, Cochrane Database Syst. Rev., 2, CD000507, 2000.
18. Kamala F. et al., Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates, Acta. Paediatr., 91,1350, 2002.
19. Dupont, I.E. and Carpentier, Y.A., Clinical use of lipid emulsions, Curr. Opin. Clin. Nutr. Metab. Care, 2, 139, 1999.
20. American Academy of Pediatrics Committee on Nutrition, Recommendations for use of intravenous fat emulsions in children, Pediatrics, 68, 738, 1981.
21. Uauy, R. and Castillo, C., Lipid requirements of infants: Implications for nutrient composition of fortified complementary foods, J. Nutr., 133, 2962S, 2003.
22. Haumont, D. et al., Plasma lipid and plasma lipoprotein concentrations in low birth weight infants given parenteral nutrition with twenty or ten percent lipid emulsion, J. Pediatr., 115, 787, 1989.
23. Haumont, D. et al., Effect of liposomal content of lipid emulsions on plasma lipid concentration in low birth weight infants receiving parenteral nutrition, J. Pediatr., 121, 759, 1992.
24. Silvers, K.M., Darlow, B.A., and Winterbourn, C.C., Lipid peroside and hydrogen peroxide formation in parenteral nutrition solutions containing multivitamins, JPEN, 25, 14, 2001.
25. Neuzil, J. et al., Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: potential toxicity of routine parenteral feeding, J. Pediatr., 126, 785, 1995.
26. Helbock, H.J., Motchnik, P.A., and Ames, B.N., Toxic hydroperoxides in intravenous lipid emulsions used in preterm infants, Pediatrics, 91, 83, 1993.
27. Baird, L.L., Protecting TPN and lipid infusions from light: reducing hydroperoxides in NICU patients, Neonatal Netw., 20, 17, 2001.
28. Freeman, J. et al., Association of intravenous lipid emulsion and coagulase negative staphylococcal bacteremia in neonatal intensive care units, N. Eng. J. Med., 323, 301, 1990.
29. Avila-Figueroa, C. et al., Intravenous lipid emulsions are major determinant of coagulase negative staphylococcal bacteremia in very low birth weight newborns, Pediatr. Infect. Dis. J., 17, 10, 1988.
30. Guillou, P.J., The effects of lipids on some aspects of the cellular immune response, Proc. Nutr. Soc., 52, 91, 1993.
31. Pomposelli, J.J. and Bistrian, B.R., Is total parenteral nutrition immunosuppressive? New Horiz., 2, 224, 1994.
32. Suchner, U. and Senftleben, U., Immune modulation by polyunsaturated fatty acids during nutrition therapy: interactions with synthesis and effects of eicosanoids, Infusionsther. Transusionsmed., 21, 167, 1994.
33. Garnacho Montero, J. et al., Lipids and immune function, Nutr. Hosp., 11, 230, 1996.
34. Yaqoob, P., Lipids and the immune response, Curr. Opin. Clin. Nutr. Metab. Care, 1, 163, 1998.
35. Lennsen, P. et al., Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation, Am. J. Clin. Nutr., 67, 927, 1998.
36. Carpentier, Y.A. and Dupont, I.E., Advances in intravenous lipid emulsions, World J. Surg., 24, 1493, 2000.
37. Freeman, J.B. et al., Safety and efficacy of a new peripheral intravenously administered amino acid solution containing glycerol and electrolytes, Surg. Gynecol. Obstet., 156, 625, 1983.
38. Lev-Ran, A. et al., Double-blind study of glycerol vs. glucose in parenteral nutrition of postsurgical insulin-treated diabetic patients, JPEN,11, 271, 1987.
39. Waxman, K. et al., Safety and efficacy of glycerol and amino acids in combination with lipid emulsion for peripheral parenteral nutrition support, JPEN, 16, 374, 1992.
40. Bresson, J.L. et al., Energy substrate utilization in infants receiving total parenteral nutrition with different glucose to fat ratios, Pediatr. Res., 25, 645, 1989.
41. Jones, M.O. et al., Glucose utilization in the surgical newborn infant receiving total parenteral nutrition, J. Pediatr. Surg., 28, 1121, 1993.
42. Coss-Bu, J.A. et al., Energy metabolism, nitrogen balance, and substrate utilization in critically ill children, Am. J. Clin. Nutr., 74, 644, 2001.
43. Sheridan, R.L. et al., Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study, JPEN, 22, 212, 1998.
44. Burke, J.J. et al., Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake, Ann. Surg., 190, 274, 1979.
45. Wolfe, R.R. et al., Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition, Metabolism, 29, 892, 1980.
46. Van den Berghe, G. et al., Intensive insulin therapy in critically ill patients. N. Engl. J. Med., 345, 1359, 2001.
47. Van den Berghe, G. et al., Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control, Crit. Care Med., 31, 359, 2003.
48. Finney, S.J. et al., Glucose control and mortality in the critically ill patients. JAMA, 290, 2041, 2003.
49. Abel, R.M. et al., Improved survival from acute renal failure after treatment with intravenous essential L-amino acids, N. Engl. J. Med., 228, 695, 1973.
50. Freund, H.R., Atamian, S., and Fischer, J.E., Comparative study of parenteral nutrition in renal failure using essential and nonessential amino acid containing solutions, Surg. Gynecol. Obstet., 151, 652, 1980.
51. Mirallo, J.M. et al., A comparison of essential and general amino acid infusion in the nutritional support of patients with compromised renal function, JPEN, 6, 109, 1982.
52. Feinstein, E.L. et al., Clinical and metabolic responses to parenteral nutrition in acute renal failure:a controlled double-blind study, Medicine, 60, 124, 1981.
53. Fsicher, J.E. and Baldessarini, J.R., False neurotransmitters and hepatic failure, Lancet, 2, 75, 1971.
54. James, J.H. et al., Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: a unified therapy of portal-systemic encephalopathy, Lancet 2, 772, 1979.
55. Ferenci, P. and Wewalka, F., Plasma amino acids in hepatic encephalopathy, J. Neural. Transm. Suppl., 14, 87, 1978.
56. Cacino, A. et al., Plasma amino acids imbalance in patients with liver disease, Am. J. Dig. Dis., 23, 591, 1978.
57. Watanabe, A. et al., Characteristics changes in serum amino acid levels in different types of hepatic encephalopathy, Gastroenterol. Jpn., 17, 218, 1982.
58. Campollo, O., Sprengers, D., and McIntyre, N., The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics, Rev. Invest. Clin., 44, 513, 1992.
59. Cerra, F.B. et al., Disease specific amino acid infusion (F080) in hepatic encephalopathy. A prospective, randomized, double-blind controlled trial, JPEN, 9, 288, 1985.
60. Rocchi, E. et al., Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?, JPEN, 9, 447, 1985.
61. Naylor, C.D. et al., Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy:a meta-analysis, Gastroenterology, 97, 1033, 1989.
62. Egberts, E.H. et al., Branched-chain amino acids in the treatment of latent portosystemic encephalopathy:a double-blind placebo-controlled crossover study, Gastroenterology, 88, 887, 1985.
63. Marchesini, G. et al., Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind randomized trial, Gastroenterology, 127, 1792, 2003.
64. Vilstrup, H. et al., Branched-chain enriched amino acid versus glucose treatment of hepatic encephalopathy:a double-blind study of 65 patients with cirrhosis, J. Hepatol., 10, 291, 1990.
65. Michel, H. et al., Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture: a controlled study of 70 patients, Liver, 5, 282, 1985.
66. Buse, M.G. and Reid, S.S., Leucine: a possible regulator of protein turnover in muscle, J. Clin. Invest., 56, 1250, 1975.
67. Cerra, F. et al., The effect of stress level, amino acid formula, and nitrogen dose on nitrogen retention in traumatic and septic stress, Ann. Surg., 205, 282, 1987.
68. Von Meyenfeldt, M.F. et al., Effect of branched-chain amino acid enrichment of total parenteral nutrition sparing and clinical outcome of sepsis and trauma: a prospective randomized double-blind trial, Br. J. Surg., 77, 924, 1990.
69. Kuhl, D.A. et al., Use of selected visceral protein measurements in the comparison of branched-chain amino acids with standard amino acids in parenteral nutrition support of injured patients, Surgery, 107, 503, 1990.
70. Bower, R.H. et al., Branched chain amino acid enriched solution in the septic patient: a randomized prospective trial, Ann. Surg., 203, 13, 1986.
71. Winters, R.W. et al., Plasma amino acids in infants receiving parenteral nutrition, in Clinical Nutrition Update: Amino Acids, Greene, H.L., Holliday, M.A., and Munro, H.N., Eds., American Medical Association, Chicago, 1977, 147.
72. Wu, P.Y.K., Edwards, N.B., and Storm, M.C., The plasma amino acid pattern of normal term breastfed infants, J. Pediatr., 109, 347, 1986.
73. Heird, W.C. et al., Pediatric parenteral amino acid mixture in low birth weight infants, J. Pediatr., 81, 41, 1988.
74. Heird, W.C. et al., Evaluation of an amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children receiving parenteral nutrition, Pediatrics, 80, 401, 1987.
75. Helms, R.A. et al., Comparison of a pediatric versus standard amino acid formulation in preterm neonates requiring parenteral nutrition, J. Pediatr., 110, 466, 1987.
76. Helms, R.A. et al., Cysteine supplementation results in normalization of plasma taurine concentrations in children receiving home parenteral nutrition, J. Pediatr., 134, 358, 1999.
77. Storm, M.C. and Helms, R.A., Cysteine supplementation normalizes plasma taurine concentrations in low birth weight premature infants requiring parenteral nutrition support, JPEN, 27, S4, 2003.
78. Novak, F. et al., Glutamine supplementation in seriousillness: a systematic review of the evidence, Crit. Care Med., 30, 2022, 2002.
79. Boelens, P.G. et al., Glutamine alimentation in catabolic state, J. Nutr., 131, 2569S, 2001.
80. Heyland, D.K., In search of the magic nutraceutical: problems with current approaches, J. Nutr., 131, 2591S, 2001.
81. Buchman AL., Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data., Am. J. Clin. Nutr., 74, 25, 2001.
82. American Medical Association Department of Foods and Nutrition, Multivitamin preparations for parenteral use: a statement by the Nutrition Advisory Group, JPEN, 3, 258, 1979.
83. Green, H.L. et al., Guidelines for the use of vitamins, trace elements, calcium magnesium, and phosphorous in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice issues of the American Society for Clinical Nutrition, Am. J. Clin. Nutr., 48, 1324, 1988.
84. Parenteral multivitamins products, drugs for human use: drug efficacy study implementation: amendment (21 CFR 5.70), Federal Register, April 20, 2000, 65, 21200.
85. Lactic acidosis traced thiamine deficiency related to nationwide shortage of multivitamins for total parenteral nutrition, Morb. Mortal. Wkly. Rep., 46, 523, 1997.
86. American Medical Association Department of Foods and Nutrition, Guideline for essential trace element preparations for parenteral use: a statement by an expert panel, JAMA, 241, 2051. 1979.
87. Baptista, R.J. et al., Utilizing selenious acid to reverse selenium deficiency in total parenteral nutrition patients, Am. J. Clin. Nutr., 39, 816, 1984.
88. Hunt, D.R. et al., Selenium depletion in burn patients, JPEN, 8, 865, 1984.
89. Moukarzel, A.A. et al., Excessive chromium intake in children receiving total parenteral nutrition, Lancet, 339, 385, 1992.
90. Mouser, J.F. et al., Chromium and zinc concentrations in pediatric patients receiving long-term parenteral nutrition, Am. J. Health Syst. Pharm., 56, 1950, 1999.
91. Polinsky, M.S. and Gruskin, A.B., Aluminum toxicity in children with chronic renal failure, J. Pediatr., 105, 758, 1984.
92. Baluarte, H.J. et al., Encephalopathy in children with chronic renal failure, Proc. Dial. Transplant. Forum, 7, 95, 1977.
93. Foley, C.M. et al., Encephalopathy in infants and children with chronic renal disease, Arch. Neurol., 38, 656, 1981.
94. Sedman, A.B. et al., Encephalopathy in childhood secondary to aluminum toxicity, J. Pediatr., 105, 836, 1984.
95. Alfrey, A.C., LeGendre, G.R., and Kaehny, W.D., The dialysis encephalopathy syndrome: possible aluminum intoxication, N. Engl. J. Med., 294, 184, 1976.
96. Ward, M.K. et al., Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminum, Lancet, 1, 841, 1978.
97. Sedman, A.B. et al., Response to aluminum in parenteral nutrition during infancy, J. Pediatr., 109, 877, 1986.
98. Koo, W.W.K. et al., Aluminum in parenteral solutions: sources and possible alternative, JPEN, 10, 591, 1986.
99. Ott, S.M. et al., Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition, Ann. Intern. Med., 98, 910, 1983.
100. Department of Health and Human Services, Food and Drug Administration, Aluminum in large and small volume parenteral used in total parenteral nutrition. Proposed rule, Fed. Regist., 63, 176, 1998.
101. Department of Health and Human Services, Food and Drug Administration, Aluminum in large and small volume parenteral used in total parenteral nutrition. Final rule, Fed. Regist., 65, 4103, 2000.
102. Department of Health and Human Services, Food and Drug Administration, Aluminum in large and small volume parenteral used in total parenteral nutrition. Final rule delay of effective date, Fed. Regist., 68, 32979, 2003.
103. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Solutions, Klein, G.L., Alfrey, A.C., Shike, M., Sherrard, D.J., Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent, Am. J. Clin. Nutr., 53, 399, 1991.
104. Brown, R., Quercia, R.Q., and Sigman, T., Total nutrient admixture; a review, JPEN, 10, 650, 1986.
105. Goldman, D.A., Martin, W.R., and Worthington, J.W., Growth of bacteria and fungi in total parenteral nutrition solutions, Am. J. Surg., 126, 314, 1973.
106. Brennan, M.F. et al., The growth of Candida albicans in nutritive solutions given parenterally, Arch. Surg., 103, 705, 1971.
107. ASHP guidelines on quality assurance of pharmacy-prepared sterile products. American Society of Health System Pharmacists, Am. J. Health Syst. Pharm., 57, 1150, 2000.
108. Safe practices for parenteral nutrition formulations: national advisory group on standards and practice guidelines for parenteral nutrition, JPEN, 22, 1, 1998.